David van de Vijver

13PUBLICATIONS
59CO-AUTHORS
Gene and molecular therapyEnvironmental epidemiologyDisease surveillanceWork integrated learning (incl. internships)Preventative health care
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 25, 2026
Epidemiologic Impact of Prioritizing Long-Acting Injectable Cabotegravir to Men Who Have Sex With Men With Low Pre-Exposure Prophylaxis Use Adherence in the Netherlands: A Mathematical Modeling Study.

|Sep 12, 2025
Perceptions of Long-Acting Injectable Pre-Exposure Prophylaxis Among Men Who Have Sex With Men and Transgender Individuals in Europe Using Structural Text Modeling Technique: Cross-Sectional Study.

Haoyi Wang, Johann Kolstee, Julio Croce Martinez

|Jul 02, 2025
Insights to a Cure: Unique Controller Phenotypes in the Rotterdam HIV-2 Cohort.

Kathryn S Hensley, Rob A Gruters, Els van Nood

|Jan 01, 2025
Novel Dolutegravir and Lenacapavir Resistance Patterns in Human Immunodeficiency Virus Type 2 Infection: A Case Report.

Jeroen J A van Kampen, Els van Nood, Rizwan Mahmud

|Sep 28, 2024
Mapping Transmission Dynamics and Drug Resistance Surveillance in the Cyprus HIV-1 Epidemic (2017-2021).

Cicek Topcu, Bram Vrancken, Johana Hezka Rodosthenous

|May 07, 2024
Intention and preference to use long-acting injectable PrEP among MSM in the Netherlands: a diffusion of innovation approach.

Haoyi Wang, Hanne M L Zimmermann, David van de Vijver

Pageof 3

Frequent Collaborators

5 joint publications

Haoyi Wang

4 joint publications

Kai J Jonas

3 joint publications

Thibault Mesplède

3 joint publications

Jeroen J A van Kampen